Localization of salmon cardiac peptide (sCP) in the heart of salmon (Salmo salar L.).
We have previously cloned and characterized a novel cardiac hormone from the salmon (Salmo salar) which has a uniquely heart-specific distribution and a low structural similarity with any other known natriuretic peptides. Specific antibodies were raised in goat against the salmon cardiac peptide. For localization and quantification, four different methods were applied: immunohistochemistry (avidin-biotin peroxidase), transmission electron microscopy, cryoimmunoelectron microscopy (protein A-gold), and a specific radioimmunoassay. Both atrial and ventricular myocytes stained immunohistochemically. The staining was similar in all myocytes and no specific myoendocrine cells were found. Within a single myocyte, both atrial and ventricular, the staining was stronger near the nucleus. Transmission electron microscopy revealed that both the atrium and the ventricle contained small sarcoplasmic granules of similar type with a diameter of 100 to 200 nm and an electron-dense core with a clear halo. The granules were typical vesicles which can be found in secretory cells utilizing the regulatory pathway. The highest number of granules was found near the nucleus, but granules were located also near the Golgi apparatus, between myofilament bundles, and in subsarcolemmal positions. Gold particles, conjugated to antibodies raised against the salmon cardiac peptide, were deposited on similar sarcoplasmic granules found in transmission electron microscopy. Among the sarcoplasmic granules with gold particles there were granules which did not show any cardiac peptide immunoreactivity. A significantly (Student's t test, P < 0.05) higher concentration of cardiac peptide was found in the heart atrium than in the ventricle, 16.2 +/- 3.5 pmol/mg tissue (n = 8) and 4.5 +/- 1.7 pmol/mg tissue (n = 8), respectively. The findings show that the salmon cardiac peptide is localized in secretory granules in both compartments of the heart. The morphology of the granules suggests that both the atrium and the ventricle utilize the regulatory pathway to release salmon cardiac peptide.
Arjamaa
O
O
Institute of Arctic Medicine, University of Oulu, Oulu, 90014, Finland.
Sormunen
R
R
Lehto
V P
VP
Vuolteenaho
O
O
D000818:Animals; D002352:Carrier Proteins / Q000032:analysis*; D003594:Cytoplasmic Granules / Q000737:chemistry; D029941:Fish Proteins; D005615:Freezing; D006325:Heart Atria / Q000737:chemistry / Q000648:ultrastructure; D006352:Heart Ventricles / Q000737:chemistry / Q000648:ultrastructure; D007124:Immunoenzyme Techniques; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D009206:Myocardium / Q000737:chemistry* / Q000648:ultrastructure; D045265:Natriuretic Peptides; D012474:Salmon; D014157:Transcription Factors / Q000032:analysis*
D002352:Carrier Proteins; D029941:Fish Proteins; D045265:Natriuretic Peptides; D014157:Transcription Factors; C403482:cardiac natriuretic peptide, Salmo salar